EMAIL THIS PAGE TO A FRIEND

BioMed research international

Angiogenin expression during early human placental development; association with blood vessel formation.


PMID 25093183

Abstract

The placenta is a transient organ essential for fetal development. During human placental development, chorionic villi grow in coordination with a large capillary network resulting from both vasculogenesis and angiogenesis. Angiogenin is one of the most potent inducers of neovascularisation in experimental models in vivo. We and others have previously mapped angiogenin expression in the human term placenta. Here, we explored angiogenin involvement in early human placental development. We studied, angiogenin expression by in situ hybridisation and/or by RT-PCR in tissues and primary cultured trophoblastic cells and angiogenin cellular distribution by coimmunolabelling with cell markers: CD31 (PECAM-1), vascular endothelial cadherin (VE-cadherin), vascular endothelial growth factor receptor-2 (VEGF-R2), Tie-2, von Willebrand factor, CD34, erythropoeitin receptor (Epo-R), alpha-smooth muscle actin, CD45, cytokeratin 7, and Ki-67. Extravillous and villous cytotrophoblasts, isolated and differentiated in vitro, expressed and secreted angiogenin. Angiogenin was detected in villous trophoblastic layers, and structured and nascent fetal vessels. In decidua, it was expressed by glandular epithelial cells, vascular cells and macrophages. The observed pattern of angiogenin expression is compatible with a role in blood vessel formation and in cross-talk between trophoblasts and endothelial cells. In view of angiogenin properties, we suggest that angiogenin may participate in placental vasculogenesis and organogenesis.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

F9259 Anti-Mouse IgM (μ-chain specific)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F1262 Anti-Rabbit IgG (whole molecule), F(ab′)2 fragment–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F0382
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F9887
Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, affinity isolated antibody, buffered aqueous solution
F6005 Anti-Rabbit IgG (whole molecule)–FITC antibody produced in goat, IgG fraction of antiserum, buffered aqueous solution
F9037
Formamide, ≥99.5% (GC), BioReagent, for molecular biology
CH3NO
221198
Formamide, ACS reagent, ≥99.5%
CH3NO
47671
Formamide, BioUltra, for molecular biology, ≥99.5% (T)
CH3NO
613339
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 3 mm × 8 in.
CH3NO
551384
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
612707
Formamide solution, NMR reference standard, 45% in DMSO-d6 (99.9 atom % D), NMR tube size 3 mm × 8 in.
CH3NO
611891
Formamide solution, NMR reference standard, 45% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
733784
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 10 mm × 8 in.
CH3NO
736201
Formamide solution, NMR reference standard, 90% in DMSO-d6 (99.9 atom % D), NMR tube size 5 mm × 8 in.
CH3NO
61739
N-Lauroylsarcosine, purum p.a., ≥98.0% (GC)
C15H29NO3
L5000
N-Lauroylsarcosine, neat, ≥95%
C15H29NO3